In this video interview, Jim Kremidas, executive director, Association for MultiSite Research Corporations (AMRC), discusses ...

Eli Lilly and Company thrives on its groundbreaking weight-loss drug tirzepatide. Learn why we could see a $50B market and ...

Sanofi picked up Blueprint Medicines in a deal worth up to $9.5 billion. Bristol Myers Squibb will pay $1.5 billion upfront ...

So far, China has made no official public threat about weaponizing its dominant position in this segment of the ...

Ratcheting up the tariff rhetoric has consistently sent the S&P 500, Nasdaq Composite, and Dow Jones Industrial Average into ...

Billions of dollars worth of U.S. biomanufacturing plant development has been announced, and site selection will likely be ...

About 15% of colon cancers are dMMR, which confers resistance to chemotherapy. ICIs have FDA approval for metastatic dMMR ...

Odin Industries is proud to announce the acquisition of Florida based A Doc on Wheels, a respected provider of mobile medical services. Effective June 3, 2025, the company will be rebranded as Shield ...

Explore Faiz Siddiqui’s gripping portrayal of Elon Musk's rise through Tesla, Twitter, and tech disruption. From self-driving ...

Hims & Hers is evolving beyond its original focus, aggressively expanding into peptides and GLP-1. Read why I reiterate my ...

Here are some highlights from the first half of the year: ...

As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the branded pharmaceuticals ...